EyePoint Pharmaceuticals
EYPT
#5901
Rank
NZ$1.76 B
Marketcap
NZ$21.29
Share price
3.24%
Change (1 day)
55.28%
Change (1 year)

Earnings for EyePoint Pharmaceuticals (EYPT)

Earnings in 2025 (TTM): -NZ$0.37 Billion

According to EyePoint Pharmaceuticals 's latest financial reports the company's current earnings are NZ$42.34 Million. In 2024 the company made an earning of -NZ$0.24 Billion a decrease over its 2023 earnings that were of -NZ$0.12 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for EyePoint Pharmaceuticals from 2003 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$0.37 Billion55.28%
2024 -NZ$0.24 Billion104.29%
2023 -NZ$0.12 Billion-29.88%
2022 -NZ$0.17 Billion87.2%
2021 -NZ$88.5 Million38.58%
2020 -NZ$63.87 Million-24.56%
2019 -NZ$84.65 Million
2017 -NZ$38.61 Million22.59%
2016 -NZ$31.5 Million-8.02%
2015 -NZ$34.24 Million-296.09%
2014 NZ$17.46 M-174.02%
2013 -NZ$23.59 Million37.42%
2012 -NZ$17.17 Million-56.29%
2011 -NZ$39.27 Million-1062.38%
2010 NZ$4.08 M-250.43%
2009 -NZ$2.72 Million-89.5%
2008 -NZ$25.85 Million
2005 -NZ$15.94 Million56.99%
2004 -NZ$10.16 Million73.7%
2003 -NZ$5.85 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Nymox Pharmaceutical
NYMX
-NZ$3.62 Million-98.99% Bahamas
NRC Health
NRC
NZ$46.11 M-112.86%๐Ÿ‡บ๐Ÿ‡ธ USA